UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spotlight Commentary – Voxelotor: A new kid on the block in the treatment of sickle cell disease

British journal of clinical pharmacology, 2022-06, Vol.88 (6), p.2564-2565

2022

Volltextzugriff (PDF)

Esophageal and Ileal Ulcers Caused by Hydroxycarbamide: A Case Report and Literature Review

Internal Medicine, 2024, pp.4105-24

2024

Volltextzugriff (PDF)

First-principles investigation of Hydroxycarbamide anticancer drug delivery by X12N12 (X = B, Al, Ga) fullerene nanostructures: A DFT, NBO and QTAIM analysis

Computational and theoretical chemistry, 2022-10, Vol.1216, p.113869, Article 113869

2022

Volltextzugriff (PDF)

Hydroxycarbamide and white matter integrity in pediatric sickle cell disease

British journal of haematology, 2019-10, Vol.187 (2), p.141-143

2019

Volltextzugriff (PDF)

Drépanocytose chez l’enfant

Journal de pédiatrie et de puériculture, 2023-10, Vol.36 (5), p.193-212

2023

Volltextzugriff (PDF)

Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis

Frontiers in hematology, 2024-05, Vol.3

2024

Volltextzugriff (PDF)

A proposed treatment algorithm for adults with Haemoglobin SC disease

British journal of haematology, 2018-08, Vol.182 (4), p.607-609

2018

Volltextzugriff (PDF)

Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso‐occlusive episodes during the randomized, open‐label HELPS study

British journal of haematology, 2022-10, Vol.199 (1), p.153-157

2022

Volltextzugriff (PDF)

Polycythemia Vera in A Cat Treated by Chemotherapy with Hydroxycarbamide

Journal of Animal Clinical Medicine, 2017/09/25, Vol.26(3), pp.130-135

2017

Volltextzugriff (PDF)

Hydroxyurea attenuates hepatic stellate cell proliferation in vitro and liver fibrogenesis in vivo

The FASEB journal, 2023-09, Vol.37 (9), p.e23124-n/a

2023

Volltextzugriff (PDF)

Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators

British journal of haematology, 2023-12, Vol.203 (5), p.712-721

2023

Volltextzugriff (PDF)

Emerging therapeutic strategies for essential thrombocythemia

Nihon Kessen Shiketsu Gakkai shi, 2021, Vol.32 (4), p.376-382, Article 2021_JJTH_32_4_376-382

KIRITO, Keita

2021

Volltextzugriff (PDF)

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

British journal of haematology, 2017-01, Vol.176 (1), p.76-85

2017

Volltextzugriff (PDF)

Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia

British journal of haematology, 2022-08, Vol.198 (4), p.693-702

2022

Volltextzugriff (PDF)

Longitudinal trend analysis of serum transferrin receptor‐1 level in a cohort of patients affected by non‐transfusion dependent thalassaemia

British journal of haematology, 2019-09, Vol.186 (5), p.e121-e123

2019

Volltextzugriff (PDF)

Additive effect of sirolimus and hydroxycarbamide on fetal haemoglobin level in kidney transplant patients with sickle cell disease

British journal of haematology, 2019-06, Vol.185 (5), p.959-961

2019

Volltextzugriff (PDF)

Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment

International journal of neonatal screening, 2019-06, Vol.5 (2), p.20-20

2019

Volltextzugriff (PDF)

Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia

British journal of haematology, 2022-06, Vol.197 (5), p.609-617

2022

Volltextzugriff (PDF)

Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics‐guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia

British journal of haematology, 2021-08, Vol.194 (3), p.617-625

2021

Volltextzugriff (PDF)

Fetal haemoglobin induction in sickle cell disease

British journal of haematology, 2018-01, Vol.180 (2), p.189-200

2018

Volltextzugriff (PDF)

Hydroxycarbamide for patients with silent cerebral infarcts: outcomes and patient preference

British journal of haematology, 2018-04, Vol.181 (1), p.145-148

2018

Volltextzugriff (PDF)

Complications dermatologiques de l’hydroxyurée au long cours

Therapie, 2017-06, Vol.72 (3), p.391-394

2017

Volltextzugriff (PDF)

Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.683-693

2022

Volltextzugriff (PDF)

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

British journal of haematology, 2016-03, Vol.172 (5), p.786-793

2016

Volltextzugriff (PDF)

Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations

British journal of haematology, 2021-03, Vol.192 (5), p.922-931

2021

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spotlight Commentary – Voxelotor: A new kid on the block in the treatment of sickle cell disease

Esophageal and Ileal Ulcers Caused by Hydroxycarbamide: A Case Report and Literature Review

First-principles investigation of Hydroxycarbamide anticancer drug delivery by X12N12 (X = B, Al, Ga) fullerene nanostructures: A DFT, NBO and QTAIM analysis

Hydroxycarbamide and white matter integrity in pediatric sickle cell disease

Drépanocytose chez l’enfant

Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis

A proposed treatment algorithm for adults with Haemoglobin SC disease

Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso‐occlusive episodes during the randomized, open‐label HELPS study

Polycythemia Vera in A Cat Treated by Chemotherapy with Hydroxycarbamide

Hydroxyurea attenuates hepatic stellate cell proliferation in vitro and liver fibrogenesis in vivo

Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators

Emerging therapeutic strategies for essential thrombocythemia

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia

Longitudinal trend analysis of serum transferrin receptor‐1 level in a cohort of patients affected by non‐transfusion dependent thalassaemia

Additive effect of sirolimus and hydroxycarbamide on fetal haemoglobin level in kidney transplant patients with sickle cell disease

Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment

Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia

Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics‐guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia

Fetal haemoglobin induction in sickle cell disease

Hydroxycarbamide for patients with silent cerebral infarcts: outcomes and patient preference

Complications dermatologiques de l’hydroxyurée au long cours

Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations

Suchergebnisse filtern